# UEEC (United Health Products, Inc.) - SEC EDGAR Financial Statements

> United Health Products, Inc. reported $0 in revenue and a net loss of $1.30M for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/UEEC
- Markdown: https://convexityos.com/fundamentals/UEEC.md
- SEC CIK: 0001096938
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001096938&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$830K | Operating profit |
| Net Income | TTM | -$1.30M | GAAP bottom line |
| Diluted EPS | TTM | -$0.01 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $38K | $59 | $643 | $4.9K | $35K | $183K | $242K |
| Cost of Revenue | -- | -- | $0 | $19K | $25 | $195 | $1.3K | $22K | $101K | $118K |
| **Gross Profit** | -- | -- | $0 | $19K | $34 | $448 | $3.6K | $13K | $82K | $124K |
| Research & Development | $270K | $356K | $599K | $625K | $237K | $245K | $666K | $77K | $20K | -- |
| Selling, General & Admin | $1.99M | $1.65M | $1.83M | $2.20M | $29.56M | $14.60M | $5.43M | $1.83M | $991K | -- |
| Total Operating Expenses | $2.26M | $2.01M | $2.43M | $2.82M | $29.80M | $14.85M | $6.10M | $1.91M | $1.01M | $642K |
| **Operating Income** | -$2.26M | -$2.01M | -$2.43M | -$2.80M | -$29.80M | -$14.85M | -$6.09M | -$1.90M | -$928K | -$517K |
| **EBITDA** | -$2.25M | -$2.00M | -$2.42M | -$2.80M | -$29.80M | -- | -- | -- | -- | -- |
| Interest Expense | $113K | $32K | $41K | $17K | $226K | $210K | $0 | $0 | $39K | $18K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | -$2.67M | -$2.00M | -$2.62M | -$1.69M | -$30.55M | -$15.71M | -$6.60M | -$5.40M | -$1.47M | -$536K |
| Basic EPS | -- | -- | -- | -- | -- | -$0.09 | -$0.04 | -$0.04 | -$0.01 | $0.00 |
| **Diluted EPS** | -$0.01 | -$0.01 | -$0.01 | -- | -- | -$0.09 | -$0.04 | -$0.03 | -$0.01 | -- |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | 183.8M | 175.9M | 172.1M | 155.8M | -- |
| Diluted Shares Outstanding | 257.0M | 248.2M | 239.1M | -- | -- | 183.8M | 175.9M | 172.1M | 155.8M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $2.7K | $3.9K | $13K | $29K | $36K | $81K | $116K | $109K |
| Selling, General & Admin | $148K | $163K | $253K | $217K | $208K | $187K | $1.37M | $677K |
| Total Operating Expenses | $151K | $167K | $266K | $246K | $244K | $268K | $1.49M | $785K |
| **Operating Income** | -$151K | -$167K | -$266K | -$246K | -$244K | -$268K | -$1.49M | -$785K |
| **EBITDA** | -$150K | -$166K | -$265K | -$245K | -$243K | -$267K | -$1.49M | -$784K |
| Interest Expense | $60K | $50K | $48K | $37K | $31K | $25K | $21K | $9.5K |
| **Net Income** | -$185K | -$284K | -$316K | -$519K | -$296K | -$315K | -$1.54M | -$814K |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | -$0.01 | -- |
| Diluted Shares Outstanding | 262.7M | 260.0M | 258.7M | -- | 257.8M | 257.1M | 254.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $13K | $22K | $46K | $17K | $31K | $190K | $29K |
| **Cash & Short-Term Investments** | -- | -- | -- | $13K | $22K | $46K | $17K | $31K | $190K | $29K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $0 | $0 | $371 | $106K |
| Inventory | -- | $0 | $34K | $35K | $0 | $70K | $77K | $32K | $37K | $62K |
| **Total Current Assets** | $105K | $192K | $152K | $71K | $27K | $116K | $93K | $113K | $240K | $197K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $0 | $101K | $0 | -- | -- | -- |
| Intangible Assets | $24K | $28K | $32K | $36K | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $211K | $78K | $133K | $279K | $0 | $101K | $0 | $0 | $0 | $0 |
| **Total Assets** | $317K | $270K | $285K | $351K | $27K | $217K | $93K | $113K | $240K | $197K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $8.1K | $268K | $178K |
| **Total Current Liabilities** | $4.05M | $1.64M | $1.95M | $2.42M | $1.17M | $1.17M | $997K | $264K | $792K | $949K |
| **Total Non-Current Liabilities** | $250K | $1.07M | $48K | $0 | $0 | $0 | $0 | $202K | $212K | $146K |
| **Total Liabilities** | $4.30M | $2.71M | $2.00M | $2.42M | $1.17M | $1.17M | $997K | $264K | $792K | $743K |
| **Total Debt (incl. Leases)** | $15K | $48K | $77K | -- | -- | -- | -- | $8.1K | $268K | $178K |
| Common Stock | $259K | $252K | $245K | $231K | $229K | $189K | $178K | $174K | $165K | $154K |
| Retained Earnings | -$81.48M | -$78.70M | -$76.70M | -$74.08M | -$72.39M | -$41.84M | -$26.13M | -$19.53M | -$14.12M | -$12.80M |
| **Total Stockholders' Equity** | -$3.98M | -$2.46M | -$1.71M | -$2.06M | -$1.14M | -$953K | -$904K | -$151K | -$552K | -$546K |
| Total Equity | -$3.98M | -$2.46M | -$1.71M | -$2.06M | -$1.14M | -$953K | -$904K | -$151K | -$552K | -$546K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Assets** | $27K | $65K | $47K | $105K | $43K | $21K | $35K | $192K |
| Intangible Assets | $21K | $22K | $23K | $24K | $25K | $26K | $27K | $28K |
| **Total Non-Current Assets** | $177K | $183K | $202K | $211K | $51K | $60K | $69K | $78K |
| **Total Assets** | $204K | $248K | $249K | $317K | $94K | $82K | $105K | $270K |
| **Total Current Liabilities** | $4.27M | $4.19M | $4.19M | $4.05M | $2.01M | $1.90M | $1.81M | $1.64M |
| Long-Term Debt | -- | -- | -- | -- | $928K | $848K | -- | -- |
| **Total Non-Current Liabilities** | $495K | $503K | $250K | $250K | $1.43M | $1.35M | $1.15M | $1.07M |
| **Total Liabilities** | $4.77M | $4.69M | $4.44M | $4.30M | $3.43M | $3.25M | $2.96M | $2.71M |
| **Total Debt (incl. Leases)** | -- | -- | $6.1K | $15K | $951K | $880K | $41K | $48K |
| Common Stock | $264K | $262K | $259K | $259K | $259K | $257K | $257K | $252K |
| Retained Earnings | -$82.26M | -$82.08M | -$81.69M | -$81.48M | -$80.83M | -$80.55M | -$80.23M | -$78.70M |
| **Total Stockholders' Equity** | -$4.56M | -$4.44M | -$4.30M | -$3.98M | -$3.37M | -$3.19M | -$2.88M | -$2.46M |
| Total Equity | -$4.56M | -$4.44M | -$4.30M | -$3.98M | -$3.37M | -$3.19M | -$2.88M | -$2.46M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.67M | -$2.00M | -$2.62M | $1.69M | $30.55M | -$15.71M | -$6.60M | -$5.40M | -$1.47M | -$536K |
| Depreciation & Amortization | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | -- | -- | -- | -- | -- |
| Stock-Based Compensation | -- | -- | -- | $483K | $26.86M | $12.72M | $3.88M | $697K | $144K | -- |
| Change in Receivables | -- | -- | -- | -- | -- | $0 | $0 | -$371 | -$100K | $97K |
| Change in Inventory | $0 | $0 | -$1.1K | $35K | $25 | -$195 | $45K | -$5.4K | $71K | $20K |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | -$72K | $45K | $179K |
| **Operating Cash Flow** | -$1.19M | -$1.19M | -$2.20M | -$620K | -$828K | -$1.33M | -$1.77M | -$1.28M | -$650K | -$473K |
| Capital Expenditure | -- | -- | -- | -- | $0 | -$101K | $0 | -- | -- | -- |
| **Free Cash Flow** | -- | -- | -- | -- | -$828K | -$1.43M | -$1.77M | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -$40K | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $0 | $0 | -$2.9K | -$40K | $0 | -$101K | $0 | $0 | $0 | -- |
| Common Stock Issued | $0 | $66K | $2.33M | $176K | $480K | $1.13M | $1.26M | $1.42M | $644K | $285K |
| Share Repurchases | -- | -- | $0 | -$50K | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $1.08M | $1.27M | $2.29M | $652K | $804K | $1.46M | $1.75M | $1.12M | $810K | $501K |
| **Net Change in Cash** | -$104K | $73K | $82K | -$8.4K | -$24K | $29K | -$15K | -$159K | $161K | $28K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$185K | -$284K | -$316K | -$519K | -$296K | -$315K | -$1.54M | -$814K |
| Depreciation & Amortization | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Operating Cash Flow** | -$194K | -$138K | -$84K | -$553K | -$175K | -$185K | -$274K | -$181K |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $175K | $161K | $20K | $600K | $193K | $180K | $110K | $307K |
| **Net Change in Cash** | -$19K | $23K | -$64K | $47K | $18K | -$4.7K | -$164K | $125K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | 50.3% | 57.6% | 69.7% | 73.3% | 36.1% | 44.9% | 51.3% |
| **Operating Margin** | -- | -- | -- | -7472.1% | -50509550.8% | -2309277.0% | -123688.1% | -5439.2% | -506.9% | -213.8% |
| **Net Profit Margin** | -- | -- | -- | -4500.0% | -51778276.3% | -2443452.6% | -134002.3% | -15490.2% | -800.8% | -221.4% |
| Return on Assets (ROA) | -842.9% | -741.4% | -921.6% | -481.4% | -113993.7% | -7236.9% | -7063.4% | -4770.2% | -611.6% | -272.0% |
| Current Ratio | 0.03x | 0.12x | 0.08x | 0.03x | 0.02x | 0.10x | 0.09x | 0.43x | 0.30x | 0.21x |
| Quick Ratio | -- | 0.12x | 0.06x | 0.02x | 0.02x | 0.04x | 0.02x | 0.31x | 0.26x | 0.14x |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | +63459.3% | -90.8% | -86.9% | -85.9% | -81.0% | -24.3% | +354.3% |
| Gross Profit Growth (YoY) | -- | -- | -100.0% | +55358.8% | -92.4% | -87.6% | -71.4% | -84.7% | -33.8% | +381.8% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -637.6% | -570.6% | -581.2% | -842.9% | -3143.7% | -3645.0% | -2954.7% | -741.4% |
| Current Ratio | 0.01x | 0.02x | 0.01x | 0.03x | 0.02x | 0.01x | 0.02x | 0.12x |
| Quick Ratio | -- | -- | -- | -- | -- | -- | -- | 0.12x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
